Dear Colleagues,
The 2023 APN Symposium will be held as a virtual event on November 29-30. While initially planned as an in-person event, the event was moved online due to various circumstances, and we ask for your understanding in this matter. However, we would like to inform you that next year's symposium will be held as an in-person event in Japan. Since its inception, APN has been dedicated to promoting the development of Pharmacometrics in the Asian region and enhancing networking opportunities. Each year, our symposium features speakers from over ten APN countries, and this year, we have also invited speakers from various Asian countries. Through these efforts, we are proud to see the APN Symposium evolve into a pan-Asian conference in the field of quantitative pharmacology. For program details and registration, please visit the following link: * Program & registration: https://apn-tokyo.jp. * Registration period: Until 5 pm on Nov. 23, JST For further information, please contact Dr. Atsunori Kaibara of the Conference Organizing Committee at kaibara_atsun...@lilly.com<mailto:kaibara_atsun...@lilly.com>. We look forward to your participation. Thank you. APN Chair Kyungsoo Park --------------------------------------- Kyungsoo Park, PhD, MD Professor of Pharmacology Yonsei University College of Medicine 50-1 Yonsei-Ro, Seoul 03722, Korea Tel +82-2-2228-1735 / Fax +82-2-313-1894 Email ksp...@yuhs.ac<mailto:ksp...@yuhs.ac> 상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above message is intended solely for the named addressee and may contain trade secret, industrial technology or privileged and confidential information otherwise protected under applicable law including the Unfair Competition Prevention and Trade Secret protection act. Any unauthorized dissemination, distribution, copying or use of the information contained in this communication is strictly prohibited. If you have received this communication in error, please notify the sender by email and delete this communication immediately.
